Related Experiment Video
Updated: Jun 4, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Design evaluation and optimization for models of hepatitis C viral dynamics
Jeremie Guedj1, Caroline Bazzoli, Avidan U Neumann
1Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA. jeremie.guedj@gmail.com
Optimizing hepatitis C viral (HCV) kinetics studies is crucial. A new method simplifies parameter estimation, potentially reducing measurements by 50% for better treatment outcome prediction.
Area of Science:
- Pharmacometrics
- Mathematical Biology
- Virology
Background:
- Mathematical modeling of hepatitis C viral (HCV) kinetics aids in understanding disease progression and treatment efficacy.
- Standard models involve complex non-linear ordinary differential equations (ODEs), posing challenges for parameter estimation with sparse data.
Purpose of the Study:
- To develop an efficient method for parameter estimation in HCV viral kinetics models using non-linear mixed-effects models.
- To address the computational difficulties in evaluating the Fisher Information Matrix (FIM) for optimal study design.
Main Methods:
- Utilized a linearized statistical model within the PFIM software to approximate the FIM, reducing computational burden.
- Compared the precision of parameter estimates across five different study designs from existing literature.
- Evaluated the impact of rationalized data sampling on the number of required measurements.
Main Results:
- Linearization of the statistical model provides a computationally efficient and accurate approximation of the FIM.
- Optimal study designs, informed by this approach, can reduce the total number of measurements by up to 50% for a given precision.
- Demonstrated the practical utility of the method for designing more efficient HCV viral kinetics studies.
Conclusions:
- The proposed method simplifies the design of optimal studies for HCV viral kinetics.
- This approach enhances the efficiency of data collection, leading to more cost-effective and informative studies.
- Facilitates better understanding of viral pathogenesis and prediction of treatment outcomes in HCV.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

